| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.08 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |